Healthcare’s next frontier

%3CP%3E%3CFONT%20face%3DVerdana%3EAsian%20firms%20could%20lead%20the%20way%20in%20huge%20biologic%20drugs%20market%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EShortly%20after%20the%20outbreak%20of%20H7N9%20avian%20flu%20in%20China%20in%202013%2C%20two%20of%20the%20country%27s%20biotechnology%20companies%20were%20quick%20to%20develop%20vaccines%2C%20put%20them%20through%20clinical%20trials%20and%20apply%20to%20get%20them%20on%20the%20market.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EHualan%20Biological%20Engineering%20Inc%20and%20Sinovac%20Biotech%20Ltd%20both%20submitted%20their%20applications%20before%20the%20end%20of%20January%20this%20year%20for%20vaccines%20for%20different%20strains%20of%20avian%20influenza%2C%20commonly%20known%20as%20%22bird%20flu%22.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ETwo%20months%20earlier%2C%20researchers%20from%20five%20different%20institutions%20in%20China%20had%20developed%20the%20country%27s%20first%20vaccine%20strain%20for%20avian%20flu%20in%20what%20Li%20Lanjuan%2C%20a%20professor%20at%20the%20Zhejiang%20University%20School%20of%20Medicine%2C%20calls%20%22a%20breakthrough%22.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22China%20didn%27t%20have%20the%20ability%20to%20develop%20our%20own%20vaccine%20strains%20in%20the%20past.%20We%20used%20to%20import%20from%20abroad%20and%20then%20put%20it%20into%20manufacture%2C%22%20Li%20says.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThese%20developments%20were%20barely%20noted%20in%20the%20press%20but%20were%20significant%20as%20they%20marked%20the%20continuation%20of%20a%20global%20trend%20in%20the%20industry.%20This%20trend%20could%20see%20Asian%20companies%20emerge%20as%20more%20globally%20important%20makers%20of%20biologic%20drugs%2C%20which%20many%20see%20as%20key%20to%20future%20medical%20advancements.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EMuch%20of%20the%20future%20of%20biologic%20medicine%2C%20from%20drugs%20to%20cure%20disease%20to%20the%20deals%20that%20will%20help%20economic%20growth%2C%20is%20now%20focused%20on%20Asia.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBiologics%20or%20%22big%20molecule%22%20drugs%2C%20as%20opposed%20to%20chemical%20formulations%2C%20are%20made%20from%20living%20organisms.%20They%20are%20manufactured%20inside%20living%20systems%20like%20microorganisms%20or%20inside%20the%20cells%20of%20plants%20or%20animals.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBiologic%20drugs%20are%20the%20next%20great%20frontier%20of%20healthcare.%20Global%20pharmaceutical%20companies%20are%20looking%20to%20biologic%20drugs%20as%20key%20to%20solving%20some%20of%20the%20most%20complex%20healthcare%20riddles%20of%20our%20time%2C%20from%20curing%20cancer%20to%20bringing%20back%20the%20elderly%20from%20the%20abyss%20of%20Alzheimer%27s%20disease.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EStepping%20up%20the%20research%20and%20development%20of%20biologic%20drugs%20could%20help%20drug%20researchers%20and%20makers%20in%20Asia%20reach%20a%20global%20market%20that%20has%20long%20been%20dominated%20by%20Western%20giants.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThe%20three%20best-selling%20drugs%20on%20the%20world%20market%20last%20year%20%28and%20seven%20of%20the%20top%2010%29%20were%20biologics.%20The%20top-selling%20drug%20in%202013%20was%20AbbVie%27s%20Humira%2C%20which%20is%20used%20for%20rheumatoid%20arthritis%20among%20other%20things%2C%20with%20global%20sales%20reaching%20%249.7%20billion.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThe%20second-best%20seller%20was%20Genentech%20Inc%27s%20Rituxan%2C%20a%20cancer%20drug%20for%20non-Hodgkin%27s%20lymphoma%2C%20with%20sales%20of%20%247.7%20billion.%20Another%20Genentech%20drug%2C%20Avastin%2C%20sold%20%247.6%20billion.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBy%202016%2C%20more%20biologic%20drugs%2C%20such%20as%20protein-based%20drugs%2C%20are%20likely%20to%20dominate%20the%20top%2010%20list%2C%20said%20Paul%20Bridges%2C%20worldwide%20head%20of%20Parexel%20Consulting%2C%20at%20the%20Bio%20Korea%202014%20International%20Convention%20in%20Seoul%20last%20month.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBy%202017%2C%20the%20global%20pharmaceutical%20market%20will%20be%20worth%20%241.2%20trillion%20and%20Asia%20will%20account%20for%20as%20much%20as%20%24250%20billion.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThese%20are%20precisely%20the%20types%20of%20drugs%20that%20the%20aging%20population%20in%20Asia%20will%20need%20in%20the%20years%20ahead.%20So%20not%20only%20are%20multinational%20companies%20setting%20up%20more%20research%20and%20development%20facilities%20in%20China%2C%20South%20Korea%2C%20Japan%2C%20Malaysia%20and%20Singapore%2C%20but%20so%20are%20a%20breed%20of%20new%20companies.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EMost%20of%20what%20is%20driving%20investment%20is%20whether%20a%20company%20is%20developing%20a%20drug%20against%20a%20disease%20that%20is%20relevant%20to%20Western%20populations%2C%20said%20Eric%20Shiozaki%2C%20principal%20of%20Denmark-based%20global%20investor%20Novo%20A/S%2C%20speaking%20in%20Hong%20Kong%20recently.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22Sometimes%20a%20disease%20is%20not%20prevalent%20in%20the%20US%20so%20they%20overlook%20it%20and%20this%20is%20an%20opportunity%20for%20Asia.%22%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EDoctors%2C%20researchers%20and%20health%20ministries%20are%20optimistic%20about%20biologic%20drugs%2C%20which%20are%20more%20expensive%20but%20often%20more%20effective%20than%20their%20chemical%20counterparts.%20This%20is%20because%20they%20reach%20deeper%20into%20the%20cellular%20structure%20of%20the%20body%20and%20are%20often%20more%20targeted.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EAsian%20governments%20have%20stepped%20up%20efforts%20to%20attract%20companies%20and%20make%20it%20easier%20for%20them%20to%20develop%20more%20biologic%20drugs%20and%2C%20perhaps%20more%20importantly%2C%20to%20get%20them%20into%20the%20hands%20of%20patients%20faster.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EIn%20April%2C%20Japan%20started%20moving%20forward%20on%20a%20plan%20to%20combine%20three%20ministries%20that%20control%20healthcare%20and%20research%20funding%20into%20a%20single%20and%20more%20effective%20institution.%20The%20plan%20is%20to%20create%20an%20organization%20like%20the%20National%20Institutes%20of%20Health%20in%20the%20United%20States%2C%20which%20would%20be%20responsible%20for%20drug%20research.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EJapan%20is%20putting%20a%20lot%20of%20hope%20on%20the%20development%20of%20expensive%20biologic%20drugs%20to%20target%20areas%20like%20cancer%2C%20says%20Hiroshi%20Tamada%2C%20vice-president%2C%20Japan%20medical%20affairs%20at%20Bristol-Myers%20Squibb%2C%20a%20multinational%20drug%20company.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22Everybody%20is%20afraid%20of%20cancer.%20That%27s%20why%20even%20for%20expensive%20drugs%20with%20small%20side%20effects%2C%20the%20government%20will%20reimburse%2C%22%20he%20says.%20%22The%20government%20has%20huge%20expectations%20for%20new%20biopharmaceuticals.%22%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ECancer%20is%20the%20No%201%20cause%20of%20death%20in%20Japan%2C%20killing%20around%20361%2C000%20people%20in%202012.%20It%20is%20also%20the%20leading%20cause%20of%20death%20in%20South%20Korea%2C%20another%20country%20that%20is%20putting%20a%20lot%20of%20hope%20in%20the%20development%20of%20biologic%20drugs.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EChina%27s%20own%20biotechnology%20industry%20grew%20fast%20last%20year%2C%20said%20Zhang%20Xiaoqiang%2C%20vice-chairman%20of%20the%20National%20Development%20and%20Reform%20Commission%2C%20speaking%20in%20March.%20China%20has%20already%20identified%20biotechnology%20as%20a%20driver%20of%20economic%20growth%20and%20cemented%20that%20in%20its%2012th%20Five%20Year%20Plan%20%282011-2015%29%2C%20and%20the%20country%20has%20the%20domestic%20size%20to%20help%20companies%20step%20up%20globally.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ESinopharm%20Group%20Co%20Ltd%2C%20the%20largest%20pharmaceutical%20company%20in%20China%2C%20and%20Fosun%20Pharma%2C%20which%20is%20part%20of%20the%20giant%20Fosun%20Group%2C%20are%20both%20looking%20to%20develop%20biologic%20drugs%20for%20the%20global%20market.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ELast%20year%2C%20China%27s%20biopharmaceutical%20manufacturing%20industry%20was%20worth%202.1%20billion%20yuan%20%28%24337%20million%29%2C%20according%20to%20Zhang.%20This%20marked%20growth%20of%2018%20percent%20over%20a%20year%20earlier.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ELike%20China%2C%20South%20Korea%20is%20also%20looking%20to%20biotechnology%20and%20the%20development%20of%20biologic%20drugs%2C%20to%20help%20shore%20up%20both%20healthcare%20and%20economic%20growth.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22The%20healthcare%20industry%20is%20a%20key%20driver%20of%20growth%2C%22%20said%20Park%20Ha%20Jung%2C%20deputy%20minister%20for%20planning%20and%20coordination%20at%20the%20Ministry%20of%20Health%20and%20Welfare%2C%20during%20last%20month%27s%20Bio%20Korea%202014%20Convention.%20%22Korea%20has%20successfully%20developed%20stem%20cell%20treatments%20and%20has%20established%20itself%20as%20a%20leader%20in%20biosimilars.%22%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3ESouth%20Korea%20plans%20to%20position%20itself%20as%20the%20seventh-largest%20market%20in%20the%20world%20for%20the%20bio%20industry%20by%202020.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EOther%20parts%20of%20Asia%20are%20lagging%20behind%2C%20although%20Indonesia%20has%20made%20some%20moves%20along%20with%20Singapore%2C%20Malaysia%20and%20Taiwan.%20But%20these%20places%20are%20typically%20home%20to%20smaller%20companies.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EIt%20is%20precisely%20these%20smaller%20companies%20that%20the%20global%20giants%20look%20to%20for%20expansion%2C%20however%2C%20as%20the%20smaller%20firms%20can%20develop%20personalized%20products%20at%20the%20heart%20of%20the%20promising%20future%20for%20biologic%20drugs.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThis%20is%20one%20key%20aspect%20of%20biologic%20drugs.%20They%20are%20more%20targeted%20and%20personalized.%20They%20typically%20focus%20on%20much%20more%20specific%20diseases%20than%20the%20broad-spectrum%20chemical%20drugs.%20A%20chemical-based%20aspirin%2C%20for%20example%2C%20can%20be%20consumed%20to%20deal%20with%20a%20number%20of%20symptoms%2C%20yet%20no%20such%20biologic%20drug%20exists.%20Aspirin%20works%20by%20blocking%20pain%20receptors.%20It%20deals%20with%20the%20symptoms%20of%20an%20illness%20but%20not%20the%20actual%20problem.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBiologic%20drugs%2C%20however%2C%20aim%20to%20tackle%20the%20problem%20by%20reaching%20into%20the%20very%20cells%20of%20the%20body%20and%20fixing%20them%2C%20rather%20than%20simply%20eliminating%20defective%20cells.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EOne%20factor%20that%20could%20help%20companies%20in%20Asia%20step%20onto%20the%20world%20stage%20is%20the%20global%20intellectual%20property%20infrastructure.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EPatents%20protect%20drugs%20from%20being%20copied%20by%20competitors%2C%20but%20the%20patents%20currently%20used%20for%20some%20best-selling%20biologics%20will%20expire%20this%20decade.%20The%20door%20will%20then%20open%20for%20companies%20to%20develop%20and%20market%20copies%20of%20these%20drugs%2C%20known%20as%20biosimilars.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThe%20expiration%20of%20patents%20also%20means%20that%20pharmaceutical%20companies%20will%20need%20to%20find%20replacement%20blockbusters%20or%20new%20ways%20to%20shore%20up%20their%20bottom%20lines.%20Some%20are%20moving%20toward%20personalized%20medicine%2C%20which%20translates%20into%20fewer%20but%20much%20more%20valuable%20sales%2C%20as%20those%20who%20buy%20these%20drugs%20will%20be%20charged%20higher%20prices.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EMany%20of%20these%20multinationals%20are%20looking%20for%20companies%20with%20products%20they%20can%20buy.%20And%20a%20lot%20of%20these%20products%20are%20being%20developed%20in%20Asia.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22The%20industry%20is%20increasingly%20looking%20to%20find%20new%20products%20to%20replace%20the%20blockbusters%20that%20are%20being%20lost%2C%22%20said%20Parexel%27s%20Bridges.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EA%20major%20challenge%20the%20Asian%20industry%20has%20struggled%20to%20overcome%20is%20innovation.%20A%20growing%20biotech%20industry%20requires%20innovation%20or%20it%20is%20relegated%20to%20making%20copies%20of%20the%20products%20created%20and%20patented%20elsewhere.%20And%20in%20Asia%2C%20for%20reasons%20that%20defy%20experts%2C%20that%20innovation%20has%20been%20hard%20to%20come%20by.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EIndia%20is%20a%20case%20in%20point.%20Throughout%20the%201990s%2C%20India%20became%20a%20world%20leader%20in%20the%20development%20of%20chemical%20drugs.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EBut%20just%20about%20every%20drug%20that%20came%20out%20of%20the%20country%20was%20a%20copy%2C%20known%20as%20generic%20drugs.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EGenerics%20helped%20lower%20the%20price%20of%20drugs%20around%20the%20world%20but%2C%20according%20to%20Yusuf%20Hamied%2C%20chairman%20of%20Mumbai-based%20generics%20maker%20Cipla%2C%20India%20was%20in%20no%20position%20to%20develop%20a%20new%20drug.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EStill%2C%20the%20global%20pharmaceutical%20industry%20is%20increasingly%20looking%20to%20the%20East.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EOver%20the%20next%20few%20years%2C%20big%20biotech%20is%20going%20to%20continually%20be%20looking%20to%20Asia.%20They%20appreciate%20the%20research%20talent%20in%20this%20part%20of%20the%20world%2C%22%20says%20Billy%20Cho%2C%20director%20of%20healthcare%20for%20Asia%20Pacific%20at%20Citibank.%20Cho%2C%20an%20investment%20banker%2C%20says%20the%20next%20wave%20of%20mergers%20and%20acquisitions%20in%20the%20biotech%20industry%20is%20likely%20to%20happen%20in%20Asia%2C%20in%20part%20because%20of%20the%20growth%20of%20the%20industry%20and%20because%20most%20of%20the%20companies%20in%20the%20West%20up%20for%20grabs%20have%20already%20been%20acquired.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EThe%20largest%20biotechnology%20companies%20in%20the%20world%20are%20now%20as%20big%20as%20the%20largest%20multinational%20pharmaceutical%20companies%uFF0Dgiant%20organizations%20that%20control%20much%20the%20world%27s%20market.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EGilead%2C%20for%20example%2C%20is%20now%20worth%20%24122%20billion%20by%20market%20capitalization%2C%20up%20from%20%2447%20billion%20in%202009.%20Another%20US%20company%2C%20Biogen%20Idec%20Inc%2C%20grew%20390%20percent%20in%20five%20years%20to%20%2468%20billion.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%22What%20you%20see%20today%20is%20that%20these%20biotech%20companies%20are%20getting%20close%20to%20big%20pharma%20size%2C%22%20says%20Cho.%20%22There%20has%20been%20a%20lot%20of%20M%26amp%3BA%20activity%20recently.%20It%20is%20pretty%20clear%20that%20M%26amp%3BA%20is%20back%2C%22%20he%20says.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EAnd%20it%20is%20happening%20right%20here.%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3EAs%20Bridges%20points%20out%3A%20%22The%20landscape%20is%20shifting%20and%20it%20is%20shifting%20towards%20Asia.%22%3C/FONT%3E%3C/P%3E%0D%0A%3CP%3E%3CFONT%20face%3DVerdana%3E%3CBR%3E%uFF08China%20Daily%uFF09%3CBR%3E%3C/FONT%3E%3C/P%3E